Agios Pharmaceuticals





Ebit Cambiamento Data
AbbVie USD 5.81B 4.36B 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amgen USD 3.96B 464M 2025-12
Arrowhead Research USD 40.81M 17.01M 2025-12
Astellas Pharma JPY 134.54B 30.13B 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR -399M 363M 2025-09
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Incyte USD 383.88M 47.44M 2025-12
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Merck USD 6.24B 1.32B 2025-12
Moderna USD -857M 597M 2025-12
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Novartis USD -9.19B 13.87B 2025-06
Novartis USD 4.48B 343M 2025-09
Pfizer USD 4.65B 71M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12


Agios Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.